UK markets closed
NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.16 -2.77 (-3.38%) GOLD FUTURES
2,329.00 +26.10 (+1.13%) DOW
38,055.40 +239.48 (+0.63%) Bitcoin GBP
45,943.77 -2,072.08 (-4.32%)
Marinus Pharmaceuticals, Inc. (MRNS)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 03:47PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 77.18M |
| Enterprise value | 638.11k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.44 |
| Price/book (mrq) | 4.60 |
| Enterprise value/revenue | 0.02 |
| Enterprise value/EBITDA | -0.01 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.89 |
| 52-week change 3 | -84.33% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 11.2600 |
| 52-week low 3 | 1.1100 |
| 50-day moving average 3 | 7.1908 |
| 200-day moving average 3 | 7.9864 |
Share statistics
| Avg vol (3-month) 3 | 1.82M |
| Avg vol (10-day) 3 | 3.04M |
| Shares outstanding 5 | 54.93M |
| Implied shares outstanding 6 | 54.93M |
| Float 8 | 38.28M |
| % held by insiders 1 | 0.97% |
| % held by institutions 1 | 106.27% |
| Shares short (15 Apr 2024) 4 | 4.52M |
| Short ratio (15 Apr 2024) 4 | 2.03 |
| Short % of float (15 Apr 2024) 4 | 8.25% |
| Short % of shares outstanding (15 Apr 2024) 4 | 8.22% |
| Shares short (prior month 15 Mar 2024) 4 | 3.57M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 23 Sept 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:4 |
| Last split date 3 | 23 Sept 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -492.86% |
Management effectiveness
| Return on assets (ttm) | -38.19% |
| Return on equity (ttm) | -213.02% |
Income statement
| Revenue (ttm) | 30.99M |
| Revenue per share (ttm) | 0.58 |
| Quarterly revenue growth (yoy) | 0.40% |
| Gross profit (ttm) | N/A |
| EBITDA | -126.13M |
| Net income avi to common (ttm) | -141.4M |
| Diluted EPS (ttm) | -2.6300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 150.29M |
| Total cash per share (mrq) | 2.75 |
| Total debt (mrq) | 110.36M |
| Total debt/equity (mrq) | 658.26% |
| Current ratio (mrq) | 4.07 |
| Book value per share (mrq) | 0.31 |
Cash flow statement
| Operating cash flow (ttm) | -118M |
| Levered free cash flow (ttm) | -70.09M |
© 2024 Yahoo. All rights reserved.